Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

172 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Amprenavir and efavirenz pharmacokinetics before and after the addition of nelfinavir, indinavir, ritonavir, or saquinavir in seronegative individuals.
Morse GD, Rosenkranz S, Para MF, Segal Y, Difrancesco R, Adams E, Brizz B, Yarasheski KE, Reichman RC. Morse GD, et al. Among authors: yarasheski ke. Antimicrob Agents Chemother. 2005 Aug;49(8):3373-81. doi: 10.1128/AAC.49.8.3373-3381.2005. Antimicrob Agents Chemother. 2005. PMID: 16048950 Free PMC article. Clinical Trial.
Compartmental pharmacokinetic analysis of oral amprenavir with secondary peaks.
Okusanya O, Forrest A, DiFrancesco R, Bilic S, Rosenkranz S, Para MF, Adams E, Yarasheski KE, Reichman RC, Morse GD; ACTG 5043 Protocol Team. Okusanya O, et al. Among authors: yarasheski ke. Antimicrob Agents Chemother. 2007 May;51(5):1822-6. doi: 10.1128/AAC.00570-06. Epub 2007 Feb 5. Antimicrob Agents Chemother. 2007. PMID: 17283195 Free PMC article.
A Randomized, Double-blinded, Placebo-controlled Trial of Sitagliptin for Reducing Inflammation and Immune Activation in Treated and Suppressed Human Immunodeficiency Virus Infection.
Dubé MP, Chan ES, Lake JE, Williams B, Kinslow J, Landay A, Coombs RW, Floris-Moore M, Ribaudo HJ, Yarasheski KE. Dubé MP, et al. Among authors: yarasheski ke. Clin Infect Dis. 2019 Sep 13;69(7):1165-1172. doi: 10.1093/cid/ciy1051. Clin Infect Dis. 2019. PMID: 30535188 Free PMC article. Clinical Trial.
Insulin resistance in HIV protease inhibitor-associated diabetes.
Yarasheski KE, Tebas P, Sigmund C, Dagogo-Jack S, Bohrer A, Turk J, Halban PA, Cryer PE, Powderly WG. Yarasheski KE, et al. J Acquir Immune Defic Syndr. 1999 Jul 1;21(3):209-16. doi: 10.1097/00126334-199907010-00005. J Acquir Immune Defic Syndr. 1999. PMID: 10421244 Free PMC article.
172 results